ALR Technologies SG (ALRTF) Receivables (2023)
ALR Technologies SG (ALRTF) reported Receivables of $41100.0 for Q4 2023, down 77.82% quarter-over-quarter from $185285.0 in Q2 2023.
ALR Technologies SG (ALRTF) Receivables (2023) Analysis & Trends
ALR Technologies SG has reported Receivables for 1 years, with the latest figure at $41100.0 in Q4 2023.
- For the quarter ending Q4 2023, Receivables changed N/A year-over-year to $41100.0; the trailing twelve-month figure through Dec 2023 stood at $41100.0 (changed N/A YoY), and the FY2023 full-year result was $41100.0, changed N/A from the prior year.
- Receivables for Q4 2023 stood at $41100.0, down from $185285.0 in the prior quarter.
- The five-year high for Receivables was $185285.0 in Q2 2023, with the low at $41100.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.09 Bn |
| 10 | ALR Technologies SG | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 41,100.00 |
| Jun 30, 2023 | 185,285.00 |